Nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Nonalcoholic fatty liver disease

Published:2015-12-17 Issue:1 Volume:1 Page:
ISSN:2056-676X
Container-title:Nature Reviews Disease Primers
language:en
Short-container-title:Nat Rev Dis Primers

Author:

Brunt Elizabeth M.,Wong Vincent W.-S.,Nobili Valerio,Day Christopher P.,Sookoian Silvia,Maher Jacquelyn J.,Bugianesi Elisabetta,Sirlin Claude B.,Neuschwander-Tetri Brent A.,Rinella Mary E.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://www.nature.com/articles/nrdp201580.pdf

Reference257 articles.

1. Yki-Järvinen, H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2, 901–910 (2014).

2. Brunt, E. M. Non-alcoholic fatty liver disease: what's new under the microscope? Gut 60, 1152–1158 (2011). This article provides a detailed description of the histological lesions of NAFLD and NASH and their correlations with pathophysiology and the clinical features of disease.

3. Torres, D. M. & Harrison, S. A. Nonalcoholic fatty liver disease: fibrosis portends a worse prognosis. Hepatology 61, 1462–1464 (2015).

4. Adams, L. A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113–121 (2005).

5. Ekstedt, M. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61, 1547–1554 (2015).

Cited by 4390 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue-specific activation of insulin signaling as a potential target for obesity-related metabolic disorders;Pharmacology & Therapeutics;2024-10

2. Trimethylamine N-oxide induces non-alcoholic fatty liver disease by activating the PERK;Toxicology Letters;2024-10

3. Strong associations between fasting lipids and glucose concentrations and ALT levels strengthened with increasing ALT quantiles;Lipids in Health and Disease;2024-09-12

4. An antifibrotic compound that ameliorates hyperglycaemia and fat accumulation in cell and HFD mouse models;Diabetologia;2024-09-09

5. Enabling target-aware molecule generation to follow multi objectives with Pareto MCTS;Communications Biology;2024-09-02